| In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles M Hadjidemetriou, Z Al-Ahmady, M Mazza, RF Collins, K Dawson, ... ACS nano 9 (8), 8142-8156, 2015 | 337 | 2015 |
| Lipid–Peptide Vesicle Nanoscale Hybrids for Triggered Drug Release by Mild Hyperthermia in Vitro and in Vivo ZS Al-Ahmady, WT Al-Jamal, JV Bossche, TT Bui, AF Drake, AJ Mason, ... ACS nano 6 (10), 9335-9346, 2012 | 261 | 2012 |
| Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles M Hadjidemetriou, Z Al-Ahmady, K Kostarelos Nanoscale 8 (13), 6948-6957, 2016 | 211 | 2016 |
| The human in vivo biomolecule corona onto PEGylated liposomes: a proof‐of‐concept clinical study M Hadjidemetriou, S McAdam, G Garner, C Thackeray, D Knight, D Smith, ... Advanced Materials 31 (4), 1803335, 2019 | 150 | 2019 |
| Chemical components for the design of temperature-responsive vesicles as cancer therapeutics Z Al-Ahmady, K Kostarelos Chemical reviews 116 (6), 3883-3918, 2016 | 142 | 2016 |
| Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia ZS Al-Ahmady, K Kostarelos Biomaterials 33 (18), 4608-4617, 2012 | 118 | 2012 |
| Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin as a potential theranostic agent N Lozano, ZS Al-Ahmady, NS Beziere, V Ntziachristos, K Kostarelos International journal of pharmaceutics 482 (1-2), 2-10, 2015 | 110 | 2015 |
| Monoclonal antibody-targeted, temperature-sensitive liposomes: in vivo tumor chemotherapeutics in combination with mild hyperthermia ZS Al-Ahmady, O Chaloin, K Kostarelos Journal of controlled release 196, 332-343, 2014 | 92 | 2014 |
| Formation of protein corona in vivo affects drug release from temperature-sensitive liposomes ZS Al-Ahmady, M Hadjidemetriou, J Gubbins, K Kostarelos Journal of controlled release 276, 157-167, 2018 | 80 | 2018 |
| Selective liposomal transport through blood brain barrier disruption in ischemic stroke reveals two distinct therapeutic opportunities ZS Al-Ahmady, D Jasim, SS Ahmad, R Wong, M Haley, G Coutts, ... ACS nano 13 (11), 12470-12486, 2019 | 77 | 2019 |
| A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona M Hadjidemetriou, Z Al-Ahmady, M Buggio, J Swift, K Kostarelos Biomaterials 188, 118-129, 2019 | 76 | 2019 |
| Translocation of silver nanoparticles in the ex vivo human placenta perfusion model characterized by single particle ICP-MS J Vidmar, K Loeschner, M Correia, EH Larsen, P Manser, A Wichser, ... Nanoscale 10 (25), 11980-11991, 2018 | 56 | 2018 |
| Triggered doxorubicin release in solid tumors from thermosensitive liposome‐peptide hybrids: Critical parameters and therapeutic efficacy ZS Al‐Ahmady, CL Scudamore, K Kostarelos International journal of cancer 137 (3), 731-743, 2015 | 44 | 2015 |
| Engineering thermosensitive liposome-nanoparticle hybrids loaded with doxorubicin for heat-triggered drug release Z Al-Ahmady, N Lozano, KC Mei, K Kostarelos International journal of pharmaceutics 514 (1), 133-141, 2016 | 40 | 2016 |
| Multiparametric profiling of engineered nanomaterials: unmasking the surface coating effect A Gallud, M Delaval, P Kinaret, VS Marwah, V Fortino, J Ytterberg, ... Advanced science 7 (22), 2002221, 2020 | 29 | 2020 |
| Selective drug delivery approaches to lesioned brain through blood brain barrier disruption ZS Al-Ahmady Expert opinion on drug delivery 15 (4), 335-349, 2018 | 26 | 2018 |
| Enhanced intraliposomal metallic nanoparticle payload capacity using microfluidic-assisted self-assembly ZS Al-Ahmady, R Donno, A Gennari, E Prestat, R Marotta, A Mironov, ... Langmuir 35 (41), 13318-13331, 2019 | 20 | 2019 |
| Nanomedicine & nanotoxicology future could be reshaped post-COVID-19 pandemic ZS Al-Ahmady, H Ali-Boucetta Frontiers in Nanotechnology 2, 610465, 2020 | 14 | 2020 |
| Re-directing nanomedicines to the spleen: A potential technology for peripheral immunomodulation S Kaur, SM Allan, ZS Al-Ahmady Journal of Controlled Release 350, 60-79, 2022 | 10 | 2022 |
| Selective brain entry of lipid nanoparticles in haemorrhagic stroke is linked to biphasic blood-brain barrier disruption ZS Al-Ahmady, BR Dickie, I Aldred, DA Jasim, J Barrington, M Haley, ... Theranostics 12 (10), 4477, 2022 | 9 | 2022 |
Kostas KostarelosNanomedicine Lab, ICREA & ICN2, Barcelona, Spain and University of Manchester, UKVerified email at icn2.cat
